Evaluating Dose Regimens of Apomorphine, an Open-Label Study

International Journal of Impotence Research - United Kingdom
doi 10.1038/sj.ijir.3900992
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Treatment of Diaphragmatic Fatigue With Inhaled Aminophylline Therapy in an Experimental Canine Model: An Open-Label, Dose-Ranging, Pharmacologic Study

Current Therapeutic Research
Pharmacology
2003English

A Phase 1b/2, Open-Label, Dose-Escalation, and Dose-Confirmation Study of Eribulin Mesilate in Combination With Capecitabine

British Journal of Cancer
Cancer ResearchOncology
2019English

Mycophenolate Mofetil for Myasthenia Gravis: An Open-Label Pilot Study

Neurology
Neurology
2001English

Open-Label, Dose Escalation Study of the Safety and Pharmacokinetic Profile of Tefibazumab in Healthy Volunteers

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2005English

Rufinamide for Refractory Focal Seizures: An Open-Label, Multicenter European Study

Seizure : the journal of the British Epilepsy Association
MedicineNeurology
2013English

Apatinib Plus Temozolomide for Recurrent Glioblastoma: An Uncontrolled, Open-Label Study

OncoTargets and Therapy
OncologyPharmacology
2019English

Phase IV, Open-Label, Safety Study Evaluating the Use of Dexmedetomidine in Pediatric Patients Undergoing Procedure-Type Sedation

Frontiers in Pharmacology
Pharmacology
2017English

Prescribing Placebos: An Experimental Examination of the Role of Dose, Expectancies, and Adherence in Open-Label Placebo Effects

Annals of Behavioral Medicine
MedicinePsychiatryMental HealthPsychology
2018English

Bioequivalence Study of Two Valsartan 160 Mg Formulations: An Open- Label, Randomised-Sequence, Single-Dose, Two-Way Crossover Study in Healthy Volunteers Under Fasting Conditions

Journal of Bioequivalence & Bioavailability
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy